Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +7.84% | +12.70% | +10.00% |
Apr. 25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
Apr. 16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.00% | 34.08M | |
-1.65% | 104B | |
+6.72% | 97.47B | |
+5.71% | 22.25B | |
-12.85% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.41% | 16.36B | |
+7.13% | 14.39B | |
+37.44% | 12.37B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Lake Street Adjusts OncoCyte Price Target to $3 From $6, Maintains Buy Rating